Radiation therapy-activated nanoparticle and immunotherapy: The next milestone in oncology?

Penninckx, Sébastien; Thariat, Juliette; Mirjolet, Céline

doi:10.1016/bs.ircmb.2023.03.005

International Review of Cell and Molecular Biology

2023

DOI: 10.1016/bs.ircmb.2023.03.005

|View full text |Cite

Radiation therapy-activated nanoparticle and immunotherapy: The next milestone in oncology?

Sébastien Penninckx¹,

Juliette Thariat²,

Céline Mirjolet³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 141 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives

Pan,

Xue,

Liang

2024

Advanced NanoBiomed Research

View full text Add to dashboard Cite

This review is aiming to systematically elucidate the unique role of nanotechnology in optimizing therapeutic modalities for combinatorial cancer immunotherapy, which enables the synergistic integration of multiple treatment strategies. In particular, nanotechnology has enabled the synergistic combination of immunotherapy with physical therapies, chemotherapy, metal therapy, and nucleic acid therapy. In each combination regimen, nanocarriers play multifaceted roles by achieving targeted codelivery of different therapeutics and optimizing each individual treatment modality. This offers new paradigms to guide precision medicine in cancer treatment. Immunotherapy alone is unlikely to achieve personalized precision medicine for cancer, and new treatment modalities are needed in the future. To overcome technical bottlenecks and realize precise regulation of the tumor microenvironment for personalized cancer treatment, it is crucial to develop novel nanosystems with integrated sensing, targeting, and therapeutic functionalities.

show abstract

Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives

Pan,

Xue,

Liang

2024

Advanced NanoBiomed Research

View full text Add to dashboard Cite

show abstract

Radiation-activated nanoparticles: Which combination to optimize radiosensitization?

Penninckx

Martinive

Mirjolet

2023

Cancer/Radiothérapie

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Radiation therapy-activated nanoparticle and immunotherapy: The next milestone in oncology?

Cited by 2 publications

References 141 publications

Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives

Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives

Radiation-activated nanoparticles: Which combination to optimize radiosensitization?

Contact Info

Product

Resources

About